ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Retail Trade

Sugi Holdings Co., Ltd.

Business Summary

Sugi Holdings Co., Ltd. engages in the management of its group companies which are in the medical business. It sells pharmaceuticals, health food, cosmetic products, and daily necessities. The company was founded in December 1976 and is headquartered in Obu, Japan.

Financial Highlights

Feb 2019 JPYUSD
Revenue488,464M4,421.30M
Gross Profit142,300M1,288.02M
Operating income25,817M233.68M
Income before tax26,053M235.81M
Net income17,940M162.38M
EBITDA33,206M300.56M
Diluted EPS287.732.60
Dividends Per Share700.63
Total Assets266,529M2,394.25M
Total liabilities99,964M897.98M
Total equity166,563M1,496.25M
Operating cash flow22,894M207.22M
Currency in JPYCurrency in USD

Historical Data

 Feb 2015Feb 2016Feb 2017Feb 2018Feb 2019
Revenue 383,644M 414,885M 430,795M 457,047M 488,464M
Gross Profit 105,626M 115,711M 120,009M 131,566M 142,300M
Operating income 20,861M 23,112M 22,833M 24,762M 25,817M
Income before tax 20,888M 22,826M 22,521M 24,559M 26,053M
Net income 12,862M 14,605M 14,947M 16,411M 17,940M
EBITDA 25,813M 28,379M 28,432M 31,217M 33,206M
Diluted EPS 203.14 230.67 236.08 259.19 287.73
Dividends Per Share 40 45 50 60 70
Total Assets 211,132M 218,762M 230,664M 254,934M 266,529M
Total liabilities 86,851M 81,980M 81,880M 92,886M 99,964M
Total equity 124,281M 136,782M 148,782M 162,046M 166,563M
Operating cash flow 31,175M 13,247M 16,912M 27,562M 22,894M
 Feb 2015Feb 2016Feb 2017Feb 2018Feb 2019
Revenue 3,541.12M 3,436.55M 3,978.91M 4,102.53M 4,421.30M
Gross Profit 974.95M 958.45M 1,108.42M 1,180.96M 1,288.02M
Operating income 192.55M 191.44M 210.89M 222.26M 233.68M
Income before tax 192.80M 189.07M 208.00M 220.44M 235.81M
Net income 118.71M 120.97M 138.05M 147.30M 162.38M
EBITDA 238.25M 235.06M 262.60M 280.20M 300.56M
Diluted EPS 1.87 1.91 2.18 2.32 2.60
Dividends Per Share 0.36 0.37 0.46 0.53 0.63
Total Assets 1,766.12M 1,938.09M 2,061.61M 2,389.14M 2,394.25M
Total liabilities 726.51M 726.29M 731.82M 870.49M 897.98M
Total equity 1,039.61M 1,211.80M 1,329.77M 1,518.63M 1,496.25M
Operating cash flow 287.75M 109.72M 156.20M 247.40M 207.22M

Valuation Measures

Feb 2019
PER16.80
ROA6.88%
ROE10.91%
Operating margin5.28%
Profit margin3.67%

Key executives

  • President & Representative Director: Eiichi Sakakibara
  • Representative Director & Vice President: Katsunori Sugiura
  • Manager-Business Planning Office: Makoto Kasai

Shareholders

  • SUGIURA FAMILY (32.5%)
  • Baillie Gifford & Co. (5.0%)
  • Select Equity Group LP (4.9%)
  • SUGIURA KATSUNORI (2.9%)
  • SUGIURA SHINYA (2.9%)
  • Newton Investment Management Ltd. (2.4%)
  • Sugi Holdings Co., Ltd. (2.3%)
  • TSURUHA Holdings, Inc. (2.0%)
  • Sands Capital Management LLC (1.6%)
  • Nomura Asset Management Co., Ltd. (1.6%)

Contact Details

Related Companies

  • Sugi Medical Co. Ltd.
  • Sugi Pharmacy Co. Ltd.

Competitors

  • cocokara fine Inc.
Last Updated on 18 Oct, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media